Niklas J Koehl

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Chronic Lymphocytic Leukemia

Molecular Docking

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Niklas J Koehl, Laura J Henze, Harriet Bennett-Lenane, Waleed Faisal, Daniel J Price, René Holm, Martin Kuentz, Brendan T Griffin
In Silico, In Vitro, and In Vivo Evaluation of Precipitation Inhibitors in Supersaturated Lipid-Based Formulations of Venetoclax. Molecular pharmaceutics 18 (6) (2021)
Patrick J O'Dwyer, Karl J Box, Niklas J Koehl, Harriet Bennett-Lenane, Christos Reppas, Rene Holm, Martin Kuentz, Brendan T Griffin
Novel Biphasic Lipolysis Method To Predict in Vivo Performance of Lipid-Based Formulations. Molecular pharmaceutics 17 (9) (2020)
Niklas J Koehl, Laura J Henze, Martin Kuentz, René Holm, Brendan T Griffin
Supersaturated Lipid-Based Formulations to Enhance the Oral Bioavailability of Venetoclax. Pharmaceutics 12 (6) (2020)
Niklas J Koehl, René Holm, Martin Kuentz, Vincent Jannin, Brendan T Griffin
Exploring the Impact of Surfactant Type and Digestion: Highly Digestible Surfactants Improve Oral Bioavailability of Nilotinib. Molecular pharmaceutics 17 (9) (2020)